Diamyd Medical AB (publ) (DMYD-B) — Cash Flow Reinvestment Rate
Diamyd Medical AB (publ) (DMYD-B) has a Cash Flow Reinvestment Rate of 2978.57x as of November 2021, reinvesting Skr62.55 Million (capex Skr42.55 Million plus investments Skr-20.00 Million) from operating cash flow of Skr21.00K. See DMYD-B free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Diamyd Medical AB (publ) Cash Flow Reinvestment Rate (2010–2020)
Historical reinvestment intensity for Diamyd Medical AB (publ) across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Diamyd Medical AB (publ).
Annual Cash Flow Reinvestment Rate for Diamyd Medical AB (publ) (2010–2020)
Year-by-year capital reinvestment analysis for Diamyd Medical AB (publ). See Diamyd Medical AB (publ) (DMYD-B) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.52x | Skr8.78 Million | Skr16.88 Million | Skr1.98 Million | ▲ +16674.5% |
| 2010 | 0.00x | Skr700.00K | Skr225.77 Million | Skr700.00K | — |